Green Thumb Industries (GTBIF) EPS (Diluted) Growth (1y) (2020 - 2026)
Green Thumb Industries (GTBIF) EPS (Diluted) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | -304.28% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 1.28% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -15.70% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 13.47% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 30.20% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 385.28% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 395.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 395.63% |
| Mar 31, 2026 | 82.97% |
| Dec 31, 2025 | 86.59% |
| Sep 30, 2025 | 176.58% |
| Jun 30, 2025 | -96.44% |
| Mar 31, 2025 | -72.78% |
| Dec 31, 2024 | 31.29% |
| Sep 30, 2024 | -18.07% |
| Jun 30, 2024 | 51.71% |
| Mar 31, 2024 | 229.33% |
| Dec 31, 2023 | 189.63% |
| Sep 30, 2023 | 5.39% |
| Jun 30, 2023 | -44.80% |
| Mar 31, 2023 | -68.25% |
| Dec 31, 2022 | -163.45% |
| Sep 30, 2022 | -54.36% |
| Jun 30, 2022 | 0.49% |
| Mar 31, 2022 | 141.08% |
| Dec 31, 2021 | 483.93% |
| Sep 30, 2021 | 86.25% |